Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[ECG changes in adriamycin therapy].

P Pötzi, J Huber, J Kühböck

    Acta Medica Austriaca. Supplement
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prognostic value of heart rate variability in patients awaiting cardiac transplantation.

    Pacing and clinical electrophysiology : PACE·1992
    Same author

    Cardiac involvement in systemic sclerosis.

    Arthritis and rheumatism·1992
    Same author

    Saccadic reaction times in patients with frontal and parietal lesions.

    Brain : a journal of neurology·1992
    Same author

    [Nitrogen laser vaporization of titanium. Alternative to PVD layering].

    Das Dental-Labor. Le Laboratoire dentaire. The Dental laboratory·1992
    Same author

    [In vitro proliferation of human bone marrow cells--inhibition by components of Candida albicans].

    Immunitat und Infektion·1992
    Same author

    Technique and results of vascular endoscopy in arterial and venous reconstructions.

    Annals of vascular surgery·1992
    Same journal

    2004 Annual Spring Meeting of the Austrian Society of Hematology and Oncology. 15-17 April 2004, Vienna, Austria. Abstracts.

    Acta medica Austriaca. Supplement·2004
    Same journal

    [Abstracts of the 31st Annual Meeting of the Austrian Society of Diabetes. 27-29 November 2003].

    Acta medica Austriaca. Supplement·2004
    Same journal

    Abstracts of the Annual Spring Meeting of the Austrian Society of Hematology and Oncology. Dornbirn, 27-29 March 2003.

    Acta medica Austriaca. Supplement·2003
    Same journal

    [30th Annual Meeting of the Austrian Society of Diabetes. 28-30 November 2002, Graz. Abstracts].

    Acta medica Austriaca. Supplement·2003
    Same journal

    Abstracts of the 4th Middle European Congress of Internal Medicine. July 1-3, 1999.

    Acta medica Austriaca. Supplement·2003
    Same journal

    1999 Spring Meeting of the Austrian Society of Hematology and Oncology. Abstracts.

    Acta medica Austriaca. Supplement·2003
    See all related articles

    Adriamycin (doxorubicin) treatment significantly impacts cardiac function, with 80% of patients showing electrocardiogram changes. These include alterations in heart rate, intervals, and arrhythmias, highlighting potential cardiotoxicity risks.

    Area of Science:

    • Cardiology
    • Oncology
    • Pharmacology

    Context:

    • Adriamycin (doxorubicin) is a widely used chemotherapy agent.
    • Monitoring cardiac function during chemotherapy is crucial for patient safety.
    • Understanding the cardiotoxic effects of Adriamycin is essential for clinical practice.

    Purpose:

    • To investigate the electrocardiogram (ECG) changes associated with Adriamycin treatment.
    • To assess the prevalence and types of cardiac abnormalities induced by Adriamycin.
    • To evaluate the cardiotoxicity profile of Adriamycin within recommended dosage limits.

    Summary:

    • 185 electrocardiograms from 39 patients undergoing Adriamycin treatment were analyzed.
    • Significant ECG changes were observed in 80% of patients, including heart rate, PQ, and QT interval variations.

    Related Experiment Videos

  • Arrhythmias such as supraventricular and ventricular ectopic beats, and AV-blocks were noted.

    • Impact:

    • Highlights the high incidence of cardiac side effects from Adriamycin therapy.
    • Emphasizes the need for regular ECG monitoring in patients receiving Adriamycin.
    • Provides data on specific ECG alterations and arrhythmias, aiding in early detection and management of cardiotoxicity.